Download
https://www.opindia.com/2021/06/us-fda-rejects-bharat-biotech-emergency-use-application-asks-ocugen-additional-trial-full-license/
US FDA rejects emergency use application for Bharat Biotech's Covaxin, asks Ocugen to launch additional trial for full approval
Share